Atlas Venture Life Science Advisors is based out of Cambridge. Atlas Venture Life Science Advisors is a registered investment advisory firm Their last reported 13F filing for Q4 2023 included $839,753,221 in managed 13F securities
and a top 10 holdings concentration of 96.44%. Atlas Venture Life Science Advisors's largest holding is Kymera Therapeutics, Inc. with shares held of 5,858,262. Whalewisdom has at least 9 13F filings
2023-12-31
Top Buys (13F)
Name | % Change |
---|---|
KRRO Korro Bio Inc. | 6.39% |
2023-12-31
Top Sells (13F)
Name | % Change |
---|---|
IRON Disc Medicine Inc | 2.4% |
2023-12-31
13F Holdings Summary
Name | $ Change |
---|---|
KYMR Kymera Therapeutics, | 17.76% |
IRON Disc Medicine Inc | 17.58% |
DYN Dyne Therapeutics, I | 15.66% |
THRD Third Harmonic Bio I | 14.25% |
DAWN Dot Therapeutics-2 I | 13.23% |
2023-12-31
13F Activity
Market Value | $0.84b, Prior: $0.65b |
New Purchases | 1 stocks |
Added To | 0 stocks |
Sold out of | 0 stocks |
Reduced holdings in | 1 stocks |
Top 10 Holdings % | 96.44% |
Turnover %[1] | 6.25% |
Turnover Alt %[2] | 1.06% |
Time Held Top 20 | 7.25 quarters |
Time Held Top 10 | 6.4 quarters |
Time Held All | 7.25 quarters |
[1]: Turnover is calculated by taking the # of new holdings (initial purchases) + the # of positions sold out of (not just reduced) divided by the total # of holdings for the quarter.
[2]: Alt Turnover is calculated by taking either the total MV of new purchases or the MV of securities sold, whichever is less, divided by the total MV of the fund.
2023-12-31
13F Sector Allocation Over Time
2023-12-31
Analysis
Top 20 equal-weighted holdings. Performance numbers calculated through 2023-12-31